US Bancorp (NYSE:USB) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.17 by 0.85 percent. This is a 9.23 percent decrease over earnings of $1.30 per share from the same period last year.
Needham Reiterates Buy on Cara Therapeutics, Maintains $26 Price Target
Needham analyst Joseph Stringer reiterates Cara Therapeutics (NASDAQ:CARA) with a Buy and maintains $26 price target.